ADMA Next Earnings Date Notes

— ADMA Biologics (ticker: ADMA) is a specialty biopharmaceutical company focused on the development, manufacturing, and commercialization of plasma-derived therapeutics for the treatment of immune deficiencies & infectious diseases. Its primary commercial products, including ASCENIV—and BIVIGAM—are FDA-approved immunoglobulin therapies designed for patients with compromised immune systems, such as those with primary humoral immunodeficiency. When listening to the next ADMA earnings call, investors should pay close attention to key business metrics: total product revenues (especially growth in ASCENIV’s market penetration), gross margin trends, progress on both plasma collection center expansion & regulatory approvals, and updates on production capacity utilization. Tracking operating expenses, positive cash flow milestones, and inventory levels can also provide insight into ADMA’s path to sustainable profitability. Management commentary around payer coverage, patient demand, and competitive positioning within the plasma therapeutics space will be highly relevant for assessing the company’s long-term growth trajectory and ability to deliver shareholder value. The next projected earnings date for ADMA is 11/4/2026 after close (stay tuned for a confirmed earnings date once announced).

ADMA Next Earnings Date FAQ

On this page we presented the ADMA Next Earnings Date information for ADMA Biologics along with recent past earnings dates. For Q2 of 2026, ADMA reported earnings of 0.160/share, with the earnings report taking place on 8/5/2026. For Q1 of 2026, ADMA reported earnings of 0.170/share, with the earnings report taking place on 5/6/2026. For Q4 of 2025, ADMA reported earnings of 0.215/share, with the earnings report taking place on 2/25/2026. For Q3 of 2025, ADMA reported earnings of 0.160/share, with the earnings report taking place on 11/5/2025. For Q2 of 2025, ADMA reported earnings of 0.140/share, with the earnings report taking place on 8/6/2025. Based on these past earnings dates, the projected next earnings date for ADMA is 11/4/2026 after market close.

Any self directed investor who desires to keep tabs on the companies they own, can benefit from maintaining a calendar of next earnings dates for each stock in their porfolio, such as ADMA Biologics. When a company files its 10Q's with the SEC a mere four times a year, that certainly puts a lot of pressure on those four out of three hundred sixty five days! To say that earnings reports are important to ADMA Biologics shareholders would thus be an understatement! That's why we started the NextEarningsDate.com website, to make it easy for self directed investors to research ADMA Biologics next earnings dates as well as any other stock out there in our coverage universe, to see when the next ADMA earnings date — or any other stock — falls on the calendar. But we also present considerably more than just the next earnings date information alone, so we encourage you to explore the additional pages linked above to look up ADMA's past earnings as well, with pages for revenue and earnings history data, as well as earnings surprises as well. Thanks for visiting, and we hope you'll think of our site the next time you need to learn about the ADMA next earnings date.